We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
+26.2%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$771M
AUM Growth
+$324M
Cap. Flow
+$208M
Cap. Flow %
26.98%
Top 10 Hldgs %
60.02%
Holding
35
New
10
Increased
8
Reduced
4
Closed
9

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$60.5M
2
UNH icon
UnitedHealth
UNH
+$44.4M
3
HCA icon
HCA Healthcare
HCA
+$40.9M
4
HAE icon
Haemonetics
HAE
+$29.7M
5
DXCM icon
DexCom
DXCM
+$26.8M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$23.8M
2
BSX icon
Boston Scientific
BSX
+$22.9M
3
PACB icon
Pacific Biosciences
PACB
+$20.4M
4
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$17.2M
5
ELV icon
Elevance Health
ELV
+$16.1M

Sector Composition

Rank Sector Weight
1 Healthcare 92.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RPRX icon
26
Royalty Pharma
RPRX
$26B
$5M 0.65%
100,000
– –
BLFS icon
27
BioLife Solutions
BLFS
$1.46B
– –
-150,000
Closed -$4.34M
BMY icon
28
Bristol-Myers Squibb
BMY
$128B
– –
-150,000
Closed -$9.04M
BSX icon
29
Boston Scientific
BSX
$67.6B
– –
-600,000
Closed -$22.9M
ELV icon
30
Elevance Health
ELV
$82.1B
– –
-60,000
Closed -$16.1M
HOLX
31
DELISTED
Hologic
HOLX
– –
-357,833
Closed -$23.8M
INSP icon
32
Inspire Medical Systems
INSP
$1.47B
– –
-70,000
Closed -$9.03M
TWST icon
33
Twist Bioscience
TWST
$5.39B
– –
-100,000
Closed -$7.6M
AXNX
34
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-303,201
Closed -$15.5M
INOV
35
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
– –
-650,000
Closed -$17.2M
1
2

Similar funds

8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
MFG
MidWestOne Financial Group Iowa City, Iowa $900M AUM 23.95% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
GGI
Galaxy Group Investments New York $843M AUM 47.48% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $967M AUM
OBWP
O'Brien Wealth Partners Waltham, Massachusetts $756M AUM 13.93% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $693M AUM 17.6% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Iron Triangle Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Iron Triangle Partners held 35 positions worth $771M, up 72% from $447M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Iron Triangle Partners deployed $208M of net new capital in Q4 2020, opening 10 new positions and adding to 8 existing holdings. Its largest new stake was Exact Sciences: 500,000 shares worth $66.2M.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 96% a quarter earlier.

On the sell side, the largest reduction was Pacific Biosciences, an estimated $20.4M trimmed.

  • Iron Triangle Partners's largest Q4 2020 buy was Exact Sciences: 500,000 shares worth $66.2M.
  • Iron Triangle Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020, an estimated $22.3M increase.
  • Iron Triangle Partners's biggest Q4 2020 reduction was Pacific Biosciences, cutting an estimated $20.4M.
  • Iron Triangle Partners fully exited Hologic in Q4 2020, selling an estimated $23.8M.
  • Iron Triangle Partners's ten largest holdings make up 60% of its $771M portfolio in Q4 2020.
  • Iron Triangle Partners opened 10 new positions and closed 9 in Q4 2020.
  • Iron Triangle Partners's portfolio value rose 72% quarter-over-quarter to $771M.

Based on Iron Triangle Partners's 13F filing for Q4 2020, filed 16 Feb 2021.